HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Trimmed by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 15.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,050,437 shares of the company's stock after selling 198,645 shares during the quarter. HealthEquity accounts for 1.4% of Stephens Investment Management Group LLC's holdings, making the stock its 11th biggest holding. Stephens Investment Management Group LLC owned approximately 1.21% of HealthEquity worth $100,789,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Paladin Wealth LLC purchased a new position in HealthEquity during the 3rd quarter valued at $39,000. UMB Bank n.a. lifted its holdings in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the period. GAMMA Investing LLC lifted its holdings in shares of HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after buying an additional 344 shares during the period. Quarry LP lifted its holdings in shares of HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after buying an additional 1,089 shares during the period. Finally, 1620 Investment Advisors Inc. purchased a new stake in shares of HealthEquity in the 3rd quarter worth $112,000. Institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of HQY traded up $2.01 during mid-day trading on Wednesday, hitting $114.51. The company's stock had a trading volume of 1,247,283 shares, compared to its average volume of 764,914. The firm has a 50-day simple moving average of $101.63 and a 200 day simple moving average of $90.37. The firm has a market capitalization of $9.92 billion, a P/E ratio of 105.06, a P/E/G ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $114.69. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the company posted $0.40 EPS. Analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock valued at $3,895,788 over the last quarter. Company insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HQY shares. Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price objective for the company. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. JMP Securities increased their price objective on HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. Finally, The Goldman Sachs Group began coverage on HealthEquity in a report on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.